&nbsp;

Jan 2025

Drug

cetuximab

Other Name(s): Erbitux®

Quick Link(s):

Aug 2023

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Sep 2025

Drug

cabazitaxel

Other Name(s): Jevtana®

Quick Link(s):

Nov 2024

Drug

PERTuzumab

Other Name(s): Perjeta®

Quick Link(s):

Sep 2022

Drug

pembrolizumab

Other Name(s): Keytruda®

Quick Link(s):

Sep 2025

Drug

carfilzomib

Other Name(s): Kyprolis®

Quick Link(s):

Feb 2024

Regimen

CYCLDOCE; CYCLDOCE+TRAS

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet (CYCLDOCE)

Jan 2024

Regimen

CAPECISP+TRAS

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer

ODB - General Benefit

capecitabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

CISPFU+TRAS

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

PGLDX

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Funding:

New Drug Funding Program

Liposomal DOXOrubicin - Single Agent Treatment of Platinum Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer

New Drug Funding Program

Liposomal Doxorubicin - Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer

pegylated liposomal DOXOrubicin

Drugs Used:

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

CRBPDOCETRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used: